A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma.

Seymour, A M

A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma. [electronic resource] - European journal of cancer (Oxford, England : 1990) Dec 1995 - 2157-63 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0959-8049

10.1016/0959-8049(95)00197-2 doi


Adjuvants, Immunologic--administration & dosage
Adult
Aged
Antibiotics, Antineoplastic--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Drug Therapy, Combination
Epirubicin--therapeutic use
Female
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Lenograstim
Leukocyte Count
Lymphoma--drug therapy
Male
Middle Aged
Neoplasms--drug therapy
Neutropenia--drug therapy
Recombinant Proteins--administration & dosage
Single-Blind Method